Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (Q2661016): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
ReferenceBot (talk | contribs)
Changed an Item
 
(2 intermediate revisions by 2 users not shown)
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1016/j.amc.2020.125555 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W3087668731 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3446096 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: A STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMOR / rank
 
Normal rank
Property / cites work
 
Property / cites work: Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics. Homogeneous and heterogeneous approaches / rank
 
Normal rank
Property / cites work
 
Property / cites work: A fractional-order infectivity SIR model / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4205270 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Mathematical modeling of the receptor-mediated endocytosis process of targeted therapeutic agents in drug delivery systems / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4399897 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Generalizations of the `linear chain trick': incorporating more flexible dwell time distributions into mean field ODE models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Models of transcription factor binding: sensitivity of activation functions to model assumptions / rank
 
Normal rank
Property / cites work
 
Property / cites work: A methodology for performing global uncertainty and sensitivity analysis in systems biology / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sensitivity Analysis in Practice / rank
 
Normal rank
Property / cites work
 
Property / cites work: A distribution-free approach to inducing rank correlation among input variables / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modeling immunotherapy of the tumor -- immune interaction / rank
 
Normal rank
Property / cites work
 
Property / cites work: The influence of time delay in a chaotic cancer model / rank
 
Normal rank

Latest revision as of 22:44, 24 July 2024

scientific article
Language Label Description Also known as
English
Phase-specific cancer-immune model considering acquired resistance to therapeutic agents
scientific article

    Statements

    Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (English)
    0 references
    0 references
    0 references
    1 April 2021
    0 references
    0 references
    cancer-immune model
    0 references
    immunotherapy
    0 references
    age-structured model
    0 references
    cancer phase-specific model
    0 references
    resistance to cancer treatment
    0 references
    pharmacokinetics and pharmacodynamics (PKPD)
    0 references
    0 references
    0 references
    0 references
    0 references